African Journal of Biotechnology
Journal / African Journal of Biotechnology / Vol. 10 No. 58 (2011) / Articles
 Open Access

Published: 2013-11-04

Articles

Pharmaceutical patents and access to essential medicines in sub-Saharan Africa

ZA Zainol, L Amin, K Jusoff, A Zahid, F Akpoviri

12376-12388

The need for biosafety regulation in developing countries: Benefits and controversies

ZA Zainol, L Amin, NS Rusly, H Hashim, NM Sidik, F Akpoviri, R Ramli

12389-12394

Biopiracy and states’ sovereignty over their biological resources

ZA Zainol, L Amin, F Akpoviri, R Ramli

12395-12408

Public attitude towards modern biotechnology

L Amin, H Hashim, NM Sidik, ZA Zainol, N Anuar

12409-12417

Risk assessment of genetically modified organisms (GMOs)

L Amin, ZA Zainol, NS Rusly, F Akpoviri, NM Sidik

12418-12424

Effect of demographic variables on public attitudes towards genetically modified insulin

L Amin, ZA Zainol, J Jahi, R Nor, M Osman, NM Mahadi

12425-12434

Ethical perception of modern biotechnology

L Amin, NAA Azlan, H Hashim, J Ahmad

12435-12447

Awareness and knowledge on modern biotechnology

L Amin, NAA Azlan, MF Hamdan, AL Samian, MS Haron

12448-12456

Ethical perception of cross-species gene transfer in plant

L Amin, NAA Azlan, H Hashim

12457-12468

Ethical perception of synthetic biology

L Amin, NAA Azlan, J Ahmad, H Hashim, AL Samian, MS Haron

12469-12480

Risks and benefits of genetically modified foods

L Amin, F Hamdan, R Hashim, MC Samani, N Anuar, ZA Zainol, K Jusoff

12481-12485

Ethical perception of human gene in transgenic banana

L Amin, NAA Azlan, J Ahmad

12486-12496

Biotechnology issues in four Malaysian mainstream newspapers

MC Samani, NI Rezali, L Amin, Z Hassan

12497-12503

Journal Identifiers


eISSN: 1684-5315
 
About AJOL
AJOL Team
AJOL Board
Donors
Partners
Sponsors
Contact
Usage Statistics
Journal Quality
About AJOL
Policies
Whistle blowing
Terms and conditions
Non-profit Organisation
 
AJOL is a non-profit, relying on your support.


AJOL's largest donor partners:
Click here to sign up for titles of interest.
Follow AJOL